Last quarter (Q4 2022), Silence Therapeutics's total revenue was £4.76M, an increase of 39.57% from the same quarter last year. In Q4, Silence Therapeutics's net income was £-13.76M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	£ 17.50M	£ 17.50M	£ 12.41M	£ 5.48M	£ 244.00K	£ 0.00
Cost of Revenue	£ 10.88M	£ 10.88M	£ 7.46M	£ 3.76M	£ 0.00	-
Gross Profit	£ 6.62M	£ 6.62M	£ 4.96M	£ 1.72M	£ 244.00K	-
Operating Expense	£ 55.21M	£ 55.21M	£ 50.77M	£ 34.19M	£ 22.98M	£ 20.57M
Operating Income	£ -48.59M	£ -48.59M	£ -45.81M	£ -32.48M	£ -22.73M	£ -20.57M
Net Non Operating Interest Income Expense	£ 179.00K	£ 179.00K	£ -2.00K	£ 113.00K	£ -6.00K	£ 39.00K
Other Income Expense	-	-	£ -44.00K	£ -3.68M	-	-
Pretax Income	£ -47.37M	£ -47.37M	£ -45.86M	£ -36.04M	£ -22.87M	£ -20.53M
Tax Provision	£ -6.88M	£ -6.88M	£ -6.45M	£ -3.49M	£ -3.29M	£ -2.12M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	£ -40.49M	£ -40.49M	£ -39.41M	£ -32.55M	£ -19.58M	£ -18.41M
Basic EPS	£ -1.27	£ -0.42	-	£ -1.19	£ -0.78	£ -0.79
Diluted EPS	£ -1.27	£ -0.42	-	£ -1.19	£ -0.78	£ -0.79
Basic Average Shares	£ 128.75M	£ 96.58M	-	£ 27.26M	£ 25.04M	£ 23.44M
Diluted Average Shares	£ 128.75M	£ 96.58M	-	£ 27.26M	£ 25.04M	£ 23.44M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	£ 347.00K	£ 374.00K	£ 416.00K
Total Expenses	£ 66.09M	£ 66.09M	£ -58.23M	£ 37.95M	£ 22.98M	£ 20.57M
Net Income From Continuing And Discontinued Operation	£ -40.49M	£ -40.49M	£ -39.41M	£ -32.55M	£ -19.58M	£ -18.41M
Normalized Income	£ -40.49M	£ -54.25M	£ -52.30M	£ -29.22M	£ -19.58M	£ -18.41M
Interest Expense	£ 47.00K	-	-	£ 16.00K	£ 33.00K	£ 0.00
EBIT	£ -47.32M	£ -47.32M	£ -45.85M	£ -36.02M	£ -22.84M	£ -20.53M
EBITDA	£ -46.84M	£ -46.84M	-	£ -35.53M	£ -22.36M	£ -20.13M

Currency in GBP

Silence Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing